Michael E. Castagna
Net Worth
Last updated:
What is Michael E. Castagna net worth?
The estimated net worth of Dr. Michael E. Castagna is at least $21,138,822 as of 29 Aug 2024. He owns shares worth $9,087,551 as insider, has earned $3,204,271 from insider trading and has received compensation worth at least $8,847,000 in MannKind Corporation.
What is the salary of Michael E. Castagna?
Dr. Michael E. Castagna salary is $983,000 per year as Chief Executive Officer & Director in MannKind Corporation.
How old is Michael E. Castagna?
Dr. Michael E. Castagna is 48 years old, born in 1977.
What stocks does Michael E. Castagna currently own?
As insider, Dr. Michael E. Castagna owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
MannKind Corporation (MNKD) | Chief Executive Officer & Director | 2,294,836 | $3.96 | $9,087,551 |
What does MannKind Corporation do?
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.
Michael E. Castagna insider trading
MannKind Corporation
Dr. Michael E. Castagna has made 18 insider trades between 2016-2024, according to the Form 4 filled with the SEC. Most recently he sold 85,106 units of MNKD stock worth $536,168 on 29 Aug 2024.
The largest trade he's ever made was exercising 150,000 units of MNKD stock on 24 May 2023. As of 29 Aug 2024 he still owns at least 2,294,836 units of MNKD stock.
MannKind key executives
MannKind Corporation executives and other stock owners filed with the SEC:
- Dr. David B. Thomson (58) Executive Vice President, Gen. Counsel & Sec.
- Dr. Michael E. Castagna (48) Chief Executive Officer & Director
- Dr. Stuart A. Tross (58) Chief People & Workplace Officer
- Mr. Joseph Kocinsky M.B.A., M.S. (61) Chief Technology Officer
- Mr. Steven B. Binder (62) Chief Financial Officer